DCT
1:14-cv-01317
Amgen Inc v. Sanofi
General
Filed
10/17/14
Cause of Action--
SectorBiotech
Status
Closed (04/12/24)
Patent Owner
Operating Company (L)
PACER
1:14-cv-01317
CourtD. Delaware
Judge | Period | PO Win Rate |
|---|---|---|
03/01/18 - 06/17/24 | 36% | |
10/22/14 - 03/01/18 | 43% |
MagistrateSherry R. Fallon
Plaintiff
Attorney
Name | Ratings |
|---|---|
L5 A | |
L3 E | |
L5 A | |
-- -- -- | |
L5 C | |
L5 B | |
L4 A | |
L3 B | |
L3 B | |
L3 D | |
L2 C | |
L2 C | |
L2 D | |
L2 E | |
L1 E | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
L5 E | |
L5 E | |
L5 E | |
L1 B | |
L4 D | |
L1 B | |
L1 B | |
L3 C | |
-- -- -- | |
L2 C | |
L4 A | |
L3 B | |
L1 B | |
L1 B | |
L2 C | |
L3 A | |
L3 D | |
L1 B | |
L1 D | |
-- -- -- | |
-- -- -- | |
London & MeadLocal | L2 D |
L2 D |
No Attorneys
Defendant
Party
Name | Ratings |
|---|---|
L5 E | |
L5 E | |
L5 E | |
L5 E | |
L5 E | |
L2 E |
No Parties
Attorney
Name | Ratings |
|---|---|
L5 A | |
L2 B | |
L5 A | |
L5 B | |
L4 A | |
L4 E | |
L3 C | |
L2 A | |
L1 D | |
-- -- -- | |
-- -- -- | |
Ashby & GeddesLocal | L5 B |
L5 A | |
L5 B | |
L4 B | |
L5 B | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
L5 E | |
L1 E | |
L4 A | |
L5 C | |
L4 A | |
L4 D | |
L3 A | |
L3 B | |
L2 E | |
L1 B | |
L1 C | |
-- -- -- | |
L4 E | |
L2 B | |
L2 D | |
L2 D | |
L1 B | |
L1 D | |
L1 E | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
L2 B | |
-- -- -- | |
-- -- -- | |
Sanofi SaLocal | -- -- -- |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- |
No Attorneys